- Home
- REX vs RXRX Comparison
REX vs RXRX Comparison
Compare REX & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REX | RXRX |
|---|---|---|
| Founded | 1980 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | REX | RXRX |
|---|---|---|
| Price | $44.12 | $3.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 187.0K | ★ 19.5M |
| Earning Date | 05-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.56 | N/A |
| Revenue | ★ $650,487,000.00 | $74,681,000.00 |
| Revenue This Year | $19.45 | $12.11 |
| Revenue Next Year | N/A | $82.52 |
| P/E Ratio | $77.52 | ★ N/A |
| Revenue Growth | 1.24 | ★ 26.92 |
| 52 Week Low | $30.02 | $2.77 |
| 52 Week High | $64.95 | $7.18 |
Technical Indicators
Market Signals| Indicator | REX | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.17 | 56.43 |
| Support Level | $41.84 | $2.88 |
| Resistance Level | $49.21 | $4.01 |
| Average True Range (ATR) | 1.41 | 0.22 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 35.36 | 77.61 |
Price Performance
Historical ComparisonAbout REX REX American Resources Corporation
REX American Resources Corp operates as a holding company that engages in investments in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include Ethanol, dried distillers grains, modified distillers grains, Distillers corn oil, Modified distillers grains, and Other.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.